Background: Insulin receptor substrate 1 (IRS-1) is a signaling molecule that exerts a key role in mediating cross talk between estrogen receptor a (ERa) and insulin-like growth factor 1 (IGF-1) in breast cancer cells. Previously, we demonstrated that a fraction of IRS-1 binds ERa, translocates to the nucleus, and modulates ERa-dependent transcription at estrogen response elements (ERE). Here, we studied structure-function relationships of the ERa:IRS-1 complex under IGF-1 and/or estradiol (E 2 ) stimulation. Results: Nuclear translocation of IRS-1 was induced by E 2 , IGF-1, and a combination of both stimuli. ERa/IRS-1 binding was direct and involved the activation function-1 (AF-1)/DNA binding domain (DBD) region of ERa and two discrete regions of IRS-1 (the N-terminal pleckstrin homology domain and a region within the C-terminus). IRS-1 knock down abrogated IGF-1-dependent transcriptional activity of unliganded ERa, but induced the activity of liganded ERa.
introduction
Insulin-like growth factor-1 (IGF-1) and 17-b-estradiol (E 2 ) have been shown to act in synergy, stimulating breast cancer cell growth and survival [1, 2] . The functional interactions between E 2 and IGF-1 signaling systems involve several transcriptional and posttranscriptional mechanisms. For example, IGF-1 can affect estrogen receptor a (ERa) action by enhancing its expression and potentiating its transcriptional activity in a ligand-independent manner [3] [4] [5] [6] [7] . On the other hand, E 2 can enhance IGF-1 signaling by upregulating the expression of IGF-1 [8] , IGF-1 receptor [9] , and some IGF-1 binding proteins [10] ; ERa also stimulates transcription and enhances stability of insulin receptor substrate 1 (IRS-1), a major IGF-1 signaling molecule [11] [12] [13] .
IRS-1 is a 130-180 kDa docking protein containing two conserved domains within the N-terminal portion. The PH (pleckstrin homology) domain mediates interactions with phospholipids and proteins containing acidic motifs. The phosphotyrosine-binding (PTB) domain couples IRS-1 with the phosphorylated IGF-1 receptor. The IRS-1 C-terminus contains several serine and tyrosine residues that can modulate its activity. The major intracellular pathways stemming from IRS-1 are activated upon its tyrosine phosphorylation and subsequent recruitment of downstream signaling molecules through Src homology domain-type interactions [14, 15] .
Numerous studies have shown that in breast cancer cells, IRS-1 signaling regulates cell proliferation, survival, and drug resistance. IRS-1 is also a key molecule sustaining efficient E 2 /IGF-1 cross talk [11, 16] . Recently, we described that in addition to its function as a signaling molecule, IRS-1 might affect nuclear processes. Specifically, IRS-1 can be found in the nucleus in breast cancer cells where it can interact with ERa. In breast tumors, nuclear colocalization of IRS-1 and ERa negatively correlated with tumor grade, size, mitotic index, and lymph node involvement in ductal breast cancer tissues [17] . The function of nuclear IRS-1 in the regulation of steroid receptor function is not well defined; our data indicated that nuclear IRS-1 can act as transcriptional regulator of liganded ERa at estrogen response elements (ERE) in DNA [18] .
In this study, we examined how E 2 , IGF-1, and the combination of both factors regulate IRS-1 nuclear translocation, its binding with ERa, and its effects on ERamediated transcription. Furthermore, using different deletion mutants of IRS-1 and ERa, we characterized structure-function relationships in the ERa:IRS-1 complex.
methods and results
E 2 and IGF-1 modulate nuclear translocation of IRS-1 and its recruitment to ERE sites Previously, we reported that IRS-1 colocalizes and coprecipitates with ERa in ER-positive MCF-7 cells and that a fraction of IRS-1 can be translocated to the nucleus together with liganded ERa [18] . Here, we asked whether IRS-1 could be transported to the nucleus in response to IGF-1 or IGF-1 plus E 2 treatments. Under serum-free medium conditions, IRS-1 was present mainly in the cytoplasm. The addition of E 2 for 1 or 4 h significantly increased nuclear abundance of IRS-1 and reduced its cytoplasmic content ( Figure 1A ). Similar effects were seen with the combination of E 2 and IGF-1. IGF-1 alone minimally increased IRS-1 nuclear translocation at 4 h ( Figure 1A ).
Next, we analyzed the association of IRS-1 with ERE sequences within the pS2 gene promoter ( Figure 1B ). We found that E 2 stimulated IRS-1 loading on pS2 ERE from 1 h to 12 h, reaching the maximum at 4 h, which was concomitant with the increased nuclear translocation of IRS-1 ( Figure 1A and B) . On the other hand, IGF-1 stimulation produced two peaks in the IRS-1 binding on pS2 ERE promoter, at 4 h and 12 h. The addition of E 2 significantly improved IGF-1-induced recruitment of IRS-1 on pS2 ERE at 4 h. Interestingly, at 8 h, IRS-1 was loaded on pS2 in response to E 2 but not under IGF-1 or E 2 plus IGF-1, indicating involvement of IRS-1 in IGF-1 signaling at these time points.
characteristics of the ERa:IRS-1 complex
To characterize the region of IRS-1 responsible for ERa binding under different stimuli, we employed IRS-1 truncation mutants (depicted in Figure 2A ) [15] . The glutathione S-transferase fusion protein incorporating IRS-1 (GST-IRS-1) mutants were incubated with 100 lg of either cytoplasmic or nuclear proteins obtained from MCF-7 cells stimulated with E 2 and/or IGF-1, or left untreated. In unstimulated cells, the strongest ERa binding mapped within the first 300 amino acids of IRS-1 (M1); a less efficient binding was also detected with the last 500 amino acids corresponding to the mutants M4 and M5 ( Figure 2B ). The IRS-1 M1 region contains the PH domain and a portion of the PTB domain [14, 19] To map ERa regions involved in IRS-1 binding, we first used ERa deletion mutants lacking the activation function-1 (AF-1)/DNA binding domain (DBD) or activation function-2 (AF-2) domain [20] (Figure 3 ). Using GST pull-down assays, we demonstrated that IRS-1 binds to AF-1/DBD, but not to AF-2 ( Figure 3A and B) . Interestingly, stimulation with E 2 , IGF-1, or both increased AF-1/DBD/IRS-1 binding in the nucleus, decreasing their cytoplasmic interactions ( Figure 3A) . A more detailed mapping of ERa:IRS-1 interfaces was done using additional GST-ERa truncation mutants ( Figure 3C ). Specifically, we tested D1 and D2 mutants that include the AF-1 domain, D3 that includes a part of the AF-1 domain and the entire DBD, D4 that covers the AF-2 domain and a part of DBD, and D5 that includes a major portion of the AF-2 domain [21] ( Figure 3C ). The results confirmed that IRS-1 binds to the AF-1/DBD domain of ERa ( Figure 3D ).
effects of IRS-1 knock down on ERa-mediated transcription at pS2 ERE
To investigate functional interactions between IRS-1 and the ERa AF-1 domain, we employed a luciferase transcription reporter assays (Figure 4 ). HeLa cells (ERa negative, IRS-1 positive) were transiently cotransfected with the ERE-responsive luciferase reporter plasmid and a plasmid encoding ERa (pSG5-HeG0, Figure 4B ), ERa with C-terminal truncation (encoding ERa AF-1/DBD domain pSG5-HE15, Figure 4C ), ERa with N-terminal truncation (encoding ERa AF-2/DBD domain, pSG5-HE19, Figure 4D ), or an empty vector (pSG5, Figure 4A ) [22] . To test the role of IRS-1 in ERa-mediated transcription, IRS-1 levels were downregulated by 70% using anti-IRS-1 siRNA, as described before [23] . We observed a significant increase of E 2 -induced ERE transcription in the absence of IRS-1 ( Figure 4B ). In contrast, downregulation of IRS-1 reduced ERE Figure 1 . Insulin receptor substrate 1 (IRS-1) associates with the pS2 ERE motif in insulin-like growth factor 1 (IGF-1) and estradiol (E 2 )-treated MCF-7 cells. (A) MCF-7 cells synchronized in serum-free medium were left untreated or were treated with 10 nM E 2 , and/or 20 ng/ml IGF-1 for 24 h. The abundance and localization of IRS-1 was analyzed by western blotting using 50 lg of cytoplasmic and nuclear proteins. The purity of subcellular protein fractions was monitored by probing for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and nucleolin, serving as cytoplasmic and nuclear protein markers, respectively. The antibodies (Abs) used were described previously [18] . (B) Chromatin immunoprecipitation assays were carried out as described previously [18] . Briefly, MCF-7 cells were treated with 10 nM E 2 and/or 20 ng/ml IGF-1, for 1, 4, 8, 12, and 24 h. Next, the cells were cross-linked with paraformaldehyde and chromatin-protein complexes were immunoprecipitated with a specific IRS-1 Ab. The presence of pS2 ERE in the resulting immunoprecipitates was analyzed by PCR [18] . discussion ERa/IGF-1 cross talk is known to influence breast cancer cell proliferation, survival, transformation, migration, and invasion [2, 24, 25] . IRS-1 is a major substrate of the IGF-1 receptor and a crucial molecule mediating ERa/IGF-1 interactions [1, 2, 14] . In breast cancer, IRS-1 overexpression has been associated with the development of the transformed phenotype, hormone independence, and drug resistance [2] . These effects have been attributed to increased IRS-1 tyrosine phosphorylation and potentiation of its signaling through the antiapoptotic Akt pathway [2, 25] . In addition to its conventional role as signal transducing molecule, IRS-1 has been found in the nuclear compartment in several cell types [15, 17, 18, 26, 27] . Recently, we demonstrated that nuclear IRS-1 is present in ERa-positive breast tumors and cell lines. In cellular systems, we found that IRS-1 can interact with ERa and influence the activity of liganded ERa [18] . Here, we characterized IRS-1 and ERa domains that are involved in functional interactions between these molecules and we studied how IGF-1 can influence nuclear localization of IRS-1 and its recruitment on ERE-containing promoters in the presence of liganded or unliganded ERa. Our results indicated that the interaction between IRS-1 and ERa does not require intermediating proteins as it can occur in vitro between GST-IRS-1 mutants and synthetic ERa. Two binding sites for ERa were mapped on IRS-1. One site mapped within the N-terminal portion of IRS-1 containing the PH domain, while the second localized within the C-terminus of IRS-1 [14] . These results are consistent with previously published observations that nuclear IRS-1 can interact with other proteins (e.g. the T antigen of JCV virus) via the PH domain [15] . The binding site for IRS-1 on ERa was mapped in the AF-1/DBD domain that contains several serine residues responsible of ligand-independent transactivation of ERa [2, 5, 28] . However, because the ERa/IRS-1 complex can bind to ERE under E 2 , which must engage an unoccupied DBD domain, we speculate that ERa binding to IRS-1 is mediated mostly by AF-1.
Nuclear translocation of IRS-1 and its interaction with ERE could be induced by both E 2 and IGF-1, but with different dynamics and efficiency. E 2 activates continuous presence of IRS-1 on ERE, while IGF-1 stimulates intermittent IRS-1 interaction with these sites. Notably, IRS-1 recruitment to ERE in response to E 2 and IGF-1 resembles that of liganded or unliganded ERa, respectively [29] , indicating that IRS-1 and ERa bind ERE motifs as one complex. The differential recruitment of the ERa:IRS-1 complex could be explained by the nature of ERa activation in response to E 2 or IGF-1. In particular, E 2 directly activates ERa by binding to the AF-2 domain [30] . Instead, activation of ERa by IGF-1 is indirect and mediated by Erk1/2 and Akt kinases that phosphorylate ERa AF-1 domain on serine residues 118 and 167, respectively [1, 5, 28, 31, 32] . Notably, the recruitment of Figure 4 . Insulin receptor substrate 1 is a transcriptional coregulator of estrogen receptor a. The experiments were carried out using HeLa cells that are ERa negative and IRS-1 positive. All transfection mixtures contained the reporter plasmid, ERE-Luc, encoding the firefly luciferase complementary DNA under the control of the TK promoter and three estrogen response element sequences and, as internal control, the plasmid pRL-Tk (Promega) encoding Renilla reniformis luciferase. The cocktail was cotransfected with either the empty vector pSG5 (A), pSG5-HeG0 encoding ERa (B), pSG5-HE15, and pSG5-HE19, code for a C-terminal truncated receptor (activation function-1/DNA binding domain (DBD), amino acids 1-281) (C) and for the N-terminal truncated receptor (activation function-2/DBD, amino acids 179-575) (D), respectively. The luciferase activity was measured using Dual luciferase assay System (Promega Madison, WI). IRS-1 knock down was obtained by transfecting cells with pSilencer-IRS-1 plasmid (shIRS1) [23] or with a control scrambled shRNA (Scrambled). Transfections and luciferase assays were carried out as described previously [18] . The results represent mean 6 standard deviation of five independent experiments. symposium article Annals of Oncology IRS-1 on ERE site in response to a combination of IGF-1 and E 2 was greater than that seen with either IGF-1 or E 2 alone, confirming synergistic effects of both mitogens on ERa.
Finally, we investigated the relevance of IRS-1/ERa interaction in ERa-dependent transcription in response to E 2 and/or IGF-1 stimulation. Using IRS-1 RNAi technology, we confirmed that IRS-1 might act as a repressor of liganded ERa on ERE [18] . It is worth noting that the effects of IRS-1 knock down were not noticeable in cells expressing the AF-1 or the AF-2 truncated mutants of ERa. This is in agreement with IRS-1 function since the absence of IRS-1 reduces the recruitment of protein kinases that phosphorylate serine residues within the AF-1 domain inducing ligand-independent activation of ERa [16, 33] . On the other hand, our results indicated that IRS-1 might be a coactivator of unliganded (IGF-1 transactivated) ERa. The negative effects of IRS-1 towards liganded ERa were abrogated under combined E 2 plus IGF-1 treatment, indicating that cooperation of both stimuli might be optimal for ERa transcriptional response. In conclusion, our data indicate that IRS-1 interacts directly with ERa in the nucleus of breast cancer cells and plays a key role in the regulation of balanced transcription of liganded and unliganded ERa. 
